Treace Medical (TMCI) CEO boosts direct stake with June share buys
Rhea-AI Filing Summary
Treace Medical Concepts Chief Executive Officer John T. Treace reported open-market share purchases and corrected an earlier reporting error. On June 10 he bought 14,715 shares of common stock at a weighted average price of $4.0240 per share, and on June 11 he bought 9,891 shares at a weighted average price of $4.0423 per share.
The amendment states the original Form 4 had misreported these purchases as 29,430 and 22,887 shares, respectively, and is being corrected for this administrative error. After these transactions, he directly holds 7,348,439 common shares, which includes 542,784 restricted stock units, and also reports indirect holdings through various trusts and his spouse, while disclaiming beneficial ownership of certain spouse- and trust-held shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 24,606 shares
Net Buy
6 txns
Insider
Treace John T.
Role
Chief Executive Officer
Bought
24,606 shs ($99K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 9,891 | $4.0423 | $40K |
| Purchase | Common Stock | 14,715 | $4.024 | $59K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 7,348,439 shares (Direct);
Common Stock — 1,605,000 shares (Indirect, By spouse);
Common Stock — 1,471,250 shares (Indirect, By spouse as trustee of a trust);
Common Stock — 1,839,063 shares (Indirect, As trustee of a trust);
Common Stock — 408,816 shares (Indirect, As co-trustee of a trust)
Footnotes (7)
- F1. The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 10, 2026 as a total of 29,430 shares purchased when in fact 14,715 shares of the Issuer's common stock were purchased.
- F2. The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F3. Includes 542,784 restricted stock units.
- F4. The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 11, 2026 as a total of 22,887 shares purchased when in fact 9,891 shares of the Issuer's common stock were purchased.
- F5. The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- F6. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
- F7. The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Key Figures
June 10 purchase: 14,715 shares at $4.0240
June 11 purchase: 9,891 shares at $4.0423
Total net shares bought: 24,606 shares
+5 more
8 metrics
June 10 purchase
14,715 shares at $4.0240
Open-market common stock buy on June 10, 2026
June 11 purchase
9,891 shares at $4.0423
Open-market common stock buy on June 11, 2026
Total net shares bought
24,606 shares
Net open-market purchases reported in this Form 4/A
Direct holdings after trades
7,348,439 shares
Common stock directly held following June 11, 2026 transaction
Included RSUs
542,784 restricted stock units
Portion of direct holdings comprised of RSUs
Indirect trust holding
1,605,000 shares
Shares held by spouse, reported as indirect ownership
Indirect spouse-trust holding
1,471,250 shares
Shares held by spouse as trustee of a trust
Indirect co-trustee holding
408,816 shares
Shares held as co-trustee of a trust
Key Terms
open-market purchase, weighted average purchase price, restricted stock units, beneficial ownership
4 terms
open-market purchase financial
"transaction_action is described as an open-market purchase of common stock"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average purchase price financial
"The price reported in Column 4 is a weighted average purchase price."
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
restricted stock units financial
"Includes 542,784 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Treace Medical Concepts (TMCI) disclose in this Form 4/A?
Treace Medical Concepts reported that CEO John T. Treace bought 24,606 common shares in open-market transactions around $4 per share. The filing also corrects previously overstated share amounts from an earlier Form 4, describing the change as an administrative error.
Why was this Treace Medical Concepts (TMCI) Form 4 amended?
The Form 4 was amended to correct an administrative error that overstated two June purchases. A June 10 trade was originally shown as 29,430 shares instead of 14,715, and a June 11 trade as 22,887 shares instead of 9,891, with all other details unchanged.